Massimiliano Lorenzini

St Bartholomew's Hospital — United Kingdom

Medicine · Health Sciences

33h-index4.5kcitations89works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiomyopathy and Myosin Studies(37), Amyloidosis: Diagnosis, Treatment, Outcomes(27), Parathyroid Disorders and Treatments(15), Cardiovascular Function and Risk Factors(14), Cardiovascular Effects of Exercise(9)

Publications86 total

Myocardial Scar in Hypertrophic Cardiomyopathy With Systolic Dysfunction
JACC. Cardiovascular imaging·2025
Disease Penetrance in Genotype-Positive But Clinically Unaffected Relatives From Families With Dilated Cardiomyopathy
JACC Heart Failure·2025Open Access
Cardiomyopathy caused by mitochondrial DNA 4300A > G variant
European Heart Journal·2025· 4 cited
Specialist services for cardiomyopathy: quality care requires diagnostic accuracy
European Heart Journal - Quality of Care and Clinical Outcomes·2025
Myocardial scar in end-stage hypertrophic cardiomyopathy: correlation with systolic function and prognostic significance
European Heart Journal·2024· 1 cited
Genotype predicts heart failure independent of left ventricular ejection fraction and NT-proBNP levels in hypertrophic cardiomyopathy
European Heart Journal·2024Open Access
Infiltrative Disease Presenting with an Inflamed Heart
Journal of Cardiovascular Magnetic Resonance·2024Open Access
Genotype influences end-stage heart failure occurrence in dilated cardiomyopathy
European Heart Journal·2023Open Access
Disease penetrance in genotype-positive relatives from families with dilated cardiomyopathy
European Heart Journal·2023· 1 citedOpen Access
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of <i>RBM20</i> Variants
Circulation Genomic and Precision Medicine·2023· 22 citedOpen Access
Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy
Circulation·2023· 45 citedOpen Access
Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?
European Heart Journal·2023· 6 cited
Understanding the Prognostic Significance of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy
JACC. Cardiovascular imaging·2022· 3 cited
Alpha-protein kinase 3 (ALPK3) truncating variants cause an autosomal dominant form of hypertrophic cardiomyopathy
European Heart Journal·2021· 4 citedOpen Access
Alpha-protein kinase 3 (<i>ALPK3</i>) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
European Heart Journal·2021· 97 citedOpen Access
Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure
JAMA Cardiology·2021· 67 citedOpen Access
The influence of age on the diagnostic yield of genetic testing in dilated cardiomyopathy
European Heart Journal·2020
How far should guidelines be followed?
European Heart Journal Supplements·2020· 4 citedOpen Access
Penetrance of hypertrophic cardiomyopathy and outcome in sarcomeric mutation carriers
European Heart Journal·2020· 2 citedOpen Access
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the <i>TTN</i> Gene
Circulation Heart Failure·2020· 154 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Claudio Rapezzi(34), Maria Letizia Bacchi Reggiani(16), Simone Longhi(14), Perry Elliott(14), Elena Biagini(13), Agnese Milandri(12), Ornella Leone(12), Christian Gagliardi(11), Candida Cristina Quarta(9), Pablo García‐Pavía(8), Fabrizio Salvi(7), Anna Corsini(7), Alessandra Ferlini(6), Juan Pablo Ochoa(6), Mohammed Akhtar(6), Luís R. Lopes(6), Lorenzo Monserrat(6), Ferdinando Pasquale(6), Pier Luigi Guidalotti(5), Petros Syrris(5)